Establishing a Provincial Registry for Recurrent Prostate Cancer: Providing Access to PSMA PET/CT in Ontario, Canada

Prostate Specific Membrane Antigen (PSMA) positron emission tomography/computed tomography (PET/CT) is becoming established as a standard of care for the (re)staging of high-risk primary and prostate cancer recurrence after primary therapy. Despite the favorable performance of this imaging modality...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Sympascho, Metser, Ur, Sistani, Golmehr, Langer, Deanna L., Bauman, Glenn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366560/
https://www.ncbi.nlm.nih.gov/pubmed/34408985
http://dx.doi.org/10.3389/fonc.2021.722430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366560/
https://www.ncbi.nlm.nih.gov/pubmed/34408985
http://dx.doi.org/10.3389/fonc.2021.722430

Ejemplares similares